Boston Partners decreased its stake in shares of Amdocs Limited (NASDAQ:DOX) by 4.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,111,712 shares of the technology company’s stock after selling 352,752 shares during the period. Boston Partners owned approximately 4.86% of Amdocs Limited worth $458,421,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of the stock. OLD National Bancorp IN increased its position in shares of Amdocs Limited by 0.6% in the second quarter. OLD National Bancorp IN now owns 4,358 shares of the technology company’s stock valued at $281,000 after buying an additional 25 shares during the period. Smith Moore & CO. increased its position in shares of Amdocs Limited by 1.0% in the first quarter. Smith Moore & CO. now owns 5,371 shares of the technology company’s stock valued at $328,000 after buying an additional 53 shares during the period. Chevy Chase Trust Holdings Inc. increased its position in shares of Amdocs Limited by 0.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 12,414 shares of the technology company’s stock valued at $757,000 after buying an additional 55 shares during the period. Financial Counselors Inc. increased its position in shares of Amdocs Limited by 1.4% in the first quarter. Financial Counselors Inc. now owns 5,127 shares of the technology company’s stock valued at $313,000 after buying an additional 70 shares during the period. Finally, Huntington National Bank increased its position in shares of Amdocs Limited by 2.6% in the second quarter. Huntington National Bank now owns 4,565 shares of the technology company’s stock valued at $295,000 after buying an additional 117 shares during the period. 89.97% of the stock is owned by hedge funds and other institutional investors.
Amdocs Limited (NASDAQ DOX) opened at 65.51 on Thursday. Amdocs Limited has a 12 month low of $54.91 and a 12 month high of $67.98. The stock has a market cap of $9.56 billion, a PE ratio of 22.76 and a beta of 0.54. The company’s 50 day moving average is $65.42 and its 200 day moving average is $62.69.
Amdocs Limited (NASDAQ:DOX) last announced its quarterly earnings data on Wednesday, August 2nd. The technology company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.06. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.73%. The company had revenue of $967 million during the quarter, compared to analyst estimates of $967.04 million. During the same quarter last year, the business posted $0.90 EPS. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. On average, analysts anticipate that Amdocs Limited will post $3.81 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be issued a dividend of $0.22 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.88 dividend on an annualized basis and a yield of 1.34%. Amdocs Limited’s payout ratio is 30.66%.
ILLEGAL ACTIVITY NOTICE: “Amdocs Limited (DOX) Position Decreased by Boston Partners” was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/08/10/amdocs-limited-dox-position-decreased-by-boston-partners.html.
Several brokerages have recently commented on DOX. Zacks Investment Research raised shares of Amdocs Limited from a “sell” rating to a “hold” rating in a research note on Monday, July 17th. Robert W. Baird upped their price objective on shares of Amdocs Limited from $62.00 to $66.00 and gave the company a “neutral” rating in a research note on Wednesday, May 10th. Barclays PLC reaffirmed a “hold” rating and set a $68.00 price objective on shares of Amdocs Limited in a research note on Friday, August 4th. Stifel Nicolaus reaffirmed a “buy” rating and set a $72.00 price objective (up from $68.00) on shares of Amdocs Limited in a research note on Thursday, August 3rd. Finally, BidaskClub raised shares of Amdocs Limited from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company’s stock. Amdocs Limited has a consensus rating of “Hold” and an average price target of $67.63.
Amdocs Limited Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.
